Editor: What To Know
- “Novotech was very pleased to establish a Partnership with PNUH, which has completed more than 340 clinical trials and is ranked 7th in terms of number of clinical trials in South Korea *GlobalData.
- Novotech notes the Partnership is designed to further support Novotech’s biotech clients run their clinical trials in the region.
- The Partnership Program is strategically designed to deliver unparalleled access to quality investigators, KOLs, and up to 4 million patients for its international biotech clients.
June 18, 2020
Novotech, the leading Asia-Pacific biotech specialist CRO, has partnered with South Korea’s world-class Pusan National University Hospital (PNUH).
Novotech notes the Partnership is designed to further support Novotech’s biotech clients run their clinical trials in the region.
Dr. Jeong Zoo Lee, the President of PNUH, said: “The PNUH site team and Novotech have worked together on a number of studies already. We have progressed to a formal agreement to support Novotech’s biotech clients across all clinical research and patient recruitment areas.
“We are pleased to partner with a regional CRO leader with such an outstanding reputation internationally,” said Dr. Lee.
Dr. Yooni Kim, Executive Director, Asia Operations said: “Novotech was very pleased to establish a Partnership with PNUH, which has completed more than 340 clinical trials and is ranked 7th in terms of number of clinical trials in South Korea *GlobalData.
“The PNUH site offers biotechs quality infrastructure, world-class medical and hospital facilities, as well as South Korea’s supportive rapid start-up environment. The main therapeutic areas at PNUH have been oncology, infectious disease, cardiovascular and gastrointestinal,” said Dr. Kim.
Novotech now has over 20 significant Partnerships with some of the leading medical institutions in the region. The Partnership Program is strategically designed to deliver unparalleled access to quality investigators, KOLs, and up to 4 million patients for its international biotech clients.
